EUVIMEDEUVIMED entdecken
Crossref

The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease

Weiwei Zhou iD, Sichang Zheng, Lei Ye, Tingwei Su, Jing Xie, Lei Jiang, Yiran Jiang, Xu Zhong, Luming Wu, Wenzhong Zhou, Weiqing Wang iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Weiwei Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Pituitary ACTH Hypersecretion, Hydrocortisone, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The ubiquitin-specific protease 8 (USP8) gene mutations are the most common driver changes in Cushing disease (CD). However, few studies have investigated the association between USP8 mutation and recurrence, and the results have been inconclusive.

Objective

To identify the predictors of recurrence and evaluate the prognostic role of USP8 mutation.

Methods

One hundred and seven patients with pathologically confirmed corticotroph adenomas were included. Somatic USP8 mutations were identified using Sanger sequencing. Recurrence predictors were estimated using multivariate Cox models, followed by receiver operating characteristic curves and Kaplan–Meier analysis.

Results

Thirteen patients (12.6%) experienced recurrence, with a mean follow-up period of 65 months after surgery. The recurrence rate was significantly higher in USP8-mutated tumors than in USP8 wildtype tumors (26.5% vs 5.8%; P = .009). Multivariate Cox models revealed that USP8 mutation, high postsurgical morning serum cortisol (MSC), and high 1-mg dexamethasone suppression test (DST) were associated with an increased 5-year recurrence risk. Furthermore, Kaplan–Meier survival analysis showed that patients with USP8 mutation, combined with either high postsurgical MSC (>2.5 μg/dL) or high 1-mg DST (>0.78 μg/dL), were more prone to recurrence (log-rank P < .001). The negative predictive values were 98% and 100%, while the positive predictive values improved from 33% to 55% and from 47% to 86%, respectively.

Conclusion

Our study corroborates USP8 mutational status in combination with postsurgical MSC or 1-mg DST as independent predictors of long-term remission, highlighting their potential role in stratifying patients at risk for suboptimal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin ThiolesterasePituitary ACTH HypersecretionHydrocortisoneMutationEndosomal Sorting Complexes Required for TransportEndopeptidasesNeoplasm Recurrence, LocalACTH-Secreting Pituitary AdenomaAdenomaHumansFemaleMaleAdultMiddle AgedPrognosisFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

USP8 geneCushing diseasepredictorsrecurrencetranssphenoidal surgery

Substanzen

Ubiquitin ThiolesteraseUSP8 protein, humanHydrocortisoneEndosomal Sorting Complexes Required for TransportEndopeptidases

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, Stat…
  • Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

ORCID-Profile: Weiwei Zhou, Weiqing Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology
  • Chinese Society of Endocrinology
  • Shanghai Medical and Health Development Foundation
  • Shanghai Shenkang Hospital Development Center
  • Shanghai Municipal Commission of Health and Family Planning

Zitieren

APA

Zhou, W., Zheng, S., Ye, L., Su, T., Xie, J., Jiang, L., Jiang, Y., Zhong, X., Wu, L., Zhou, W., & Wang, W. (2025). The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf269

Vancouver

Zhou W, Zheng S, Ye L, Su T, Xie J, Jiang L, et al. The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf269

BibTeX
@article{Zhou2025,
  author = {Zhou, Weiwei and Zheng, Sichang and Ye, Lei and Su, Tingwei and Xie, Jing and Jiang, Lei and Jiang, Yiran and Zhong, Xu and Wu, Luming and Zhou, Wenzhong and Wang, Weiqing},
  title = {The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf269}
}
Kostenlos starten →